Genome-wide association study for germline prognostic markers in colorectal cancer

Genome-wide association study for germline prognostic markers in colorectal cancer

Bibliographic Details
Main Authors:	Walther, A, Domingo, E, Mesher, D, Johnstone, E, Orntoft, T, Sasieni, P, Dunlop, M, Tejpar, S, Kerr, D, Tomlinson, I, Grp, V, Grp, P
Format:	Journal article
Published:	2010

Similar Items

Genetic prognostic and predictive markers in colorectal cancer.
by: Walther, A, et al.
Published: (2009)

Erratum: Genetic prognostic and predictive markers in colorectal cancer (Nature Reviews Cancer (2009) 9 (489-499))
by: Walther, A, et al.
Published: (2011)

Effect of SNP haplotypes associated with colorectal cancer risk on outcome
by: Walther, A, et al.
Published: (2008)

Genetic prognostic markers in colorectal cancer.
by: Houlston, R, et al.
Published: (1997)

Is sidedness prognostically important across all stages of colorectal cancer?
by: Kerr, D, et al.
Published: (2016)

What is the role and impact of molecular markers on treatment decisions in the adjuvant setting of colorectal cancer?
by: Johnstone, E, et al.
Published: (2008)

REporting recommendations for tumor MARKer prognostic studies (REMARK)
by: McShane, L, et al.
Published: (2005)

REporting recommendations for tumor MARKer prognostic studies (REMARK)
by: McShane, L, et al.
Published: (2005)

Germline epimutations of APC are not associated with inherited colorectal polyposis.
by: Hitchins, M, et al.
Published: (2006)

p27(kip1) localisation is an independent prognostic marker for colorectal cancer.
by: Royds, J, et al.
Published: (1997)

EPHB2 germline variants in patients with colorectal cancer or hyperplastic polyposis
by: Kokko, A, et al.
Published: (2006)

Germline determinants of colorectal cancer risk and outcome
by: Freeman-Mills, L
Published: (2017)

Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.
by: Palles, C, et al.
Published: (2013)

Frequency of germline hereditary non-polyposis colorectal cancer gene mutations in patients with multiple or early onset colorectal adenomas.
by: Beck, N, et al.
Published: (1997)

Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer
by: Houlston, R, et al.
Published: (2008)

Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer.
by: Houlston, R, et al.
Published: (2008)

Germline HNPCC gene variants have little influence on the risk for sporadic colorectal cancer.
by: Tomlinson, I, et al.
Published: (1997)

Genome-wide association study of germline variants and breast cancer-specific mortality
by: Escala-Garcia, M, et al.
Published: (2019)

Mutation burden and other molecular markers of prognosis in the QUASAR2 clinical trial of colorectal cancer treated with curative intent
by: Domingo, E, et al.
Published: (2018)

MLH1 germline epimutations as a factor in hereditary nonpolyposis colorectal cancer.
by: Hitchins, M, et al.
Published: (2005)

Colorectal cancer in the adjuvant setting: perspectives on treatment and the role of prognostic factors
by: Cascinu, S, et al.
Published: (2003)

Germline and somatic polymerase ε and δ mutations define a new class of hypermutated colorectal and endometrial cancers.
by: Briggs, S, et al.
Published: (2013)

Germline mutations but not somatic changes at the MYH locus contribute to the pathogenesis of unselected colorectal cancers.
by: Halford, SE, et al.
Published: (2003)

CLINICAL PROGNOSTIC MARKERS IN MULTIPLE-SCLEROSIS
by: Paty, D, et al.
Published: (1979)

Germline epigenetic silencing of the tumor suppressor gene PTPRJ in early-onset familial colorectal cancer.
by: Venkatachalam, R, et al.
Published: (2010)

Follow up after colorectal surgery (the FACS trial)
by: Corkhill, A, et al.
Published: (2004)

Prognostic value of p53, hMLH1, hMSH2, MGMT and COX-2 in the QUASAR-1 Dukes' stage B colorectal cancer cohort
by: Jubb, A, et al.
Published: (2002)

Unravelling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis
by: Agraz-Doblas, A, et al.
Published: (2019)

THROMBOCYTOSIS AS A PREDICTIVE AND PROGNOSTIC MARKER IN ADVANCED COLORECTAL CANCER (ACRC): RESULTS OF THE MRC COIN TRIAL EXPLORED
by: Maughan, T, et al.
Published: (2010)

VICTOR: A PHASE III PLACEBO-CONTROLLED TRIAL OF ROFECOXIB IN COLORECTAL CANCER PATIENTS FOLLOWING SURGICAL RESECTION
by: Midgley, R, et al.
Published: (2008)

Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer
by: Teo, M, et al.
Published: (2014)

A genome-wide scan of 10 000 gene-centric variants and colorectal cancer risk.
by: Webb, E, et al.
Published: (2009)

Primer: an evidence-based approach to prognostic markers.
by: Altman, D, et al.
Published: (2005)

Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer.
by: Domingo, E, et al.
Published: (2013)

Prognostic value of serum markers for prostate cancer.
by: Stenman, U, et al.
Published: (2005)

Genome wide profiling in oral squamous cell carcinoma identifies a four genetic marker signature of prognostic significance
by: Vincent-Chong, V.K., et al.
Published: (2017)

Determination Of Prognostic Markers For Cervical Cancer
by: Ahmad, Rahmatul Wahida
Published: (2008)

Germline APC variants in patients with multiple colorectal adenomas, with evidence for the particular importance of E1317Q.
by: Lamlum, H, et al.
Published: (2000)

A prospective, blinded analysis of thymidylate synthase and p53 expression as prognostic markers in the adjuvant treatment of colorectal cancer.
by: Popat, S, et al.
Published: (2006)

Reporting recommendations for tumor marker prognostic studies.
by: McShane, L, et al.
Published: (2005)